CTOs on the Move


 
We created the first FDA-cleared app-enabled thermometer because, from our work in the health systems within the U.S. and across impoverished nations throughout the world, we`ve learned that an elevated temperature is often the first sign of sickness. By building intelligence into a once basic thermometer and turning it into a connected device, we`re able to keep an eye on illnesses from beginning to end. We can more quickly alert users when fever and symptoms warrant closer monitoring or a visit to the doctor. Our network of connected thermometers can even offer helpful insights such as common illnesses that may be ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kinsahealth.com
  • 535 Mission St 18th Floor
    San Francisco, CA USA 94105
  • Phone: 415.236.4811

Executives

Name Title Contact Details

Funding

Kinsa raised $17M on 03/08/2017

Similar Companies

Not Soap, Radio

Not Soap, Radio is a West Hollywood, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

r3 Health Partners

r3 Health Partners is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Memorial Health System of East Texas

Memorial Health System of East Texas, doing business as Memorial Medical Center of East Texas, operates not-for-profit hospitals in Lufkin, Livingston, and San Augustine. It offers diabetes, dialysis, emergency, homecare, lab imaging, intensive care, orthopedics, rehabilitation, robotic surgery, sexual assault nurse examiner, sleep lab, social, stroke, surgery, and wound care and hyperbaric oxygen services, as well as cancer, cardiovascular and stroke, infusion, ambulatory, and women’s and children’s center services. The company was founded in 1949 and is based in Lufkin, Texas.

KaloBios

KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.

ProPharma Group

ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the complete product lifecycle through an advise-build-operate model. Our end-to-end suite of consulting solutions de-risk and accelerate high-profile drug and device programs, ultimately improving patient health and safety. Discover how ProPharma can help you inspire the future of science!